Clovis Oncology to highlight Rubraca and Lucitanib non-clinical data at AACR virtual annual meeting June 22-24

Clovis Oncology to highlight Rubraca and Lucitanib non-clinical data at AACR virtual annual meeting June 22-24

BOULDER -- Clovis Oncology, Inc . (NASDAQ: CLVS) today announced four abstracts showcasing non-clinical data from rucaparib and lucitanib development programs have been accepted for on-demand... Read More

Wednesday June 17, 2020 0 comments Tags: Boulder, Clovis Oncology, Patrick J. Mahaffy, Rubraca, Lucitanib